The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT)

Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies

Xavier Bosch, Montserrat Rovira, Marta Sitges et al. · Journal of the American College of Cardiology · 2013 · 627 citations

Medicine, Cardiology, Pharmacology +11

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

Daniela Cardinale, Maria Teresa Sandri, Alessandro Martinoni et al. · Journal of the American College of Cardiology · 2000 · 558 citations

Medicine, Cardiology, Oncology +12

Cardiotoxicity Associated With High-Dose Cyclophosphamide Therapy

John S. Gottdiener · Archives of Internal Medicine · 1981 · 470 citations

Medicine, Cardiology, Pharmacology +17

Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor

MA Goldberg, JH Antin, EC Guinan et al. · Blood · 1986 · 359 citations · Full text

Medicine, Pharmacology, Toxicology +14

Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens.

Alan C. Braverman, Joseph H. Antin, Maureen Plappert et al. · Journal of Clinical Oncology · 1991 · 336 citations

Pharmacy, Pharmacology, Pharmacotherapy +17